Inability of transforming growth factor-β to cause SnoN degradation leads to resistance to transforming growth factor-β-induced growth arrest in esophageal cancer cells

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4782-4788

  Edmiston, Jeffery S ^a   Yeudall, W Andrew ^a   Chung, Theodore D ^b   Lebman, Deborah A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGUS CANCER; GENE REPRESSION; GENETIC TRANSCRIPTION; GROWTH DISORDER; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; GENES, MYC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 19644368166     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4354     Document Type: Article

References (39)

1. Wong R, Malthaner R. Esophageal cancer: a systematic review. Curr Probl Cancer 2000;24:297-373.
2. McManus DT, Olaru A, Meltzer SJ. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res 2004;64:1561-9.
3. Akhurst RJ. Derynck R. TGF-β signaling in cancer - a double-edged sword. Trends Cell Biol 2001:11:544-51.
4. Massague J. Blain SW, Lo RS. TGF β signaling In growth control, cancer, and heritable disorders. Cell 2000;103: 295-309.
5. Roberts AB, Wakefield LM. The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci U S A 2003;100:8621-3.
6. McEarchern JA, Koble JJ, Mack V, et al. Invasion and metastasis of a mammary tumor involves TGF-β signaling. Int J Cancer 2001;91:76-82.
7. Feng XH, Liang YY, Liang M, Zhai W, Lin X. Direct Interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell 2002;9:133-43.
8. Warner BJ, Blain SW, Seoane J, Massague J. Myc downregulation by transforming growth factor 3 required for activation of the p15(Ink4b) G(1) arrest pathway. Mol Cell Biol 1999;19:5913-22.
9. Claassen GF, Harm SR. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest. Proc Natl Acad Sci U S A 2000;97:9498-503.
10. Chen CR, Kang Y, Massague J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program. Proc Natl Acad Sci U S A 2001;98:992-9.
11. Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B. Sensitivity to transforming growth factor-β1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ 1996;7:1291-304.
12. Baldwin RL, Tran H, Karlan BY. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling. Cancer Res 2003;63:1413-9.
13. Lebman DA, Edmiston JS, Chung TD, Snyder SR. Heterogeneity in the transforming growth factor β response of esophageal cancer cells. Int J Oncol 2002;20:1241-6.
14. Chen CR, Kang Y, Siegel FM, Massague J. E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell 2002;110:19-32.
15. Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF. Transforming growth factor β-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol 2004;24:2546-59.
16. Yagi K, Furuhashi M, Aoki H, et al. c-myc is a downstream target of the Smad pathway. J Biol Chem 2002;277:854-61.
17. Shinagawa T, Dong HD, Xu M, Maekawa T, Ishii S. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor In mice. EMBO J 2000;19:2280-91.
18. Liu X, Sun Y, Weinberg RA, Lodish HF. Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev 2001;12: 1-8.
19. Boyer PL, Colmenares C, Stavnezer E, Hughes SH. Sequence and biological activity of chicken snoN cDNA clones. Oncogene 1993;8:457-66.
20. He J, Tegen SB, Krawitz AR, Martin GS, Luo K. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J Biol Chem 2003;278:30540-7.
21. Macias-Silva M, Li W, Leu JI, Crissey MA, Taub R. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-β signals during liver regeneration. J Biol Chem 2002;277:28483-90.
22. Stroschein SL, Bonni S, Wrana JL, Luo K. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 2001;15: 2822-36.
23. Wan Y, Liu X, Kirschner MW. The anaphase-promoting complex mediates TGF-β signaling by targeting SnoN for destruction. Mol Cell 2001;8:1027-39.
24. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 1999;286:771-4.
25. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc Natl Acad Sci U S A 1999;96:12442-7.
26. Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol Cell 1999;4: 499-509.
27. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-7.
28. Depoortere F, Pirson I, Bartek J. Dumont JE, Roger PP. Transforming growth factor β(I) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell 2000;11:1061-76.
29. Medrano EE. Repression of TGF-β signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 2003;22:3123-9.
30. Hahn SA, Schutte M. Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
31. Grady WM, Myeroff LL, Swinler SE, et al. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res 1999;59:320-4.
32. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF·β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
33. Samowitz WS, Curtin K, Neuhausen S, Schaffer D, Slattery ML. Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability. Genes Chromosomes Cancer 2002; 35:368-71.
34. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001;10:917-23.
35. Osawa H, Shitara Y, Shoji H, et al. Mutation analysis of transforming growth factor β type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma. Int J Oncol 2000;17:723-8.
36. Ueki N, Hayman MJ. Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J Biol Chem 2003;278:24858-54.
37. Wu JW, Krawitz AR, Chai J, et al. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling. Cell 2002;111:357-67.
38. Ueki N, Hayman MJ. Direct interaction of Ski with either Smad3 or Smad4 Is necessary and sufficient for Ski-mediated repression of transforming growth factor-β signaling. J Biol Chem 2003;278:32489-92.
39. Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K. c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene 2004;23:5068-76.